The Misericordia Hospital is a hospital located in Grosseto, Tuscany, Italy. It is home to the International School of Robotic Surgery, founded in 2004 by Pier Cristoforo Giulianotti.

During the past decade, Ospedale Della Misericordia; U.O. Di Medicina Ia - Oncologia Medica conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Ospedale Della Misericordia; U.O. Di Medicina Ia - Oncologia Medica" are "Breast Cancer" (1 trials) and "Triple-Negative Breast Cancer" (1 trials). Many other conditions were trialed in "Ospedale Della Misericordia; U.O. Di Medicina Ia - Oncologia Medica" in a lesser frequency.

Most popular intervention types in "Ospedale Della Misericordia; U.O. Di Medicina Ia - Oncologia Medica" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "5-Fluorouracil" (1 trials), "Atezolizumab" (1 trials), "Cyclophosphamide" (1 trials), "Docetaxel" (1 trials) and "Doxorubicin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale Della Misericordia; U.O. Di Medicina Ia - Oncologia Medica" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Ospedale Della Misericordia; U.O. Di Medicina Ia - Oncologia Medica". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Ospedale Della Misericordia; U.O. Di Medicina Ia - Oncologia Medica, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale Della Misericordia; U.O. Di Medicina Ia - Oncologia Medica, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".